You just read:

Mirum Pharmaceuticals to Present Phase 2 Clinical Results of Maralixibat in Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis at the International Liver Congress

News provided by

Mirum Pharmaceuticals

Mar 27, 2019, 08:00 ET